Simvastatin in nephrotic syndrome

Kidney International, Supplement

Volumn 56, Issue 71, 1999, Pages

  Olbricht, Christoph J ^a   Wanner, Christoph ^a   Thiery, Joachim ^a   Basten, Achim ^a  

^a Klinik fur Nieren und Hochdruckkrankheiten   (Germany)

Author keywords

Cholesterol; Hyperlipidemia; Low density lipoprotein; Progressive renal disease

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MULTICENTER STUDY; NEPHROTIC SYNDROME; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE CLEARANCE; HYPERLIPIDEMIA; INULIN CLEARANCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEINURIA;

ADULT; ANTILIPEMIC AGENTS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MULTICENTER STUDIES; NEPHROTIC SYNDROME; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; SIMVASTATIN; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 0032974556     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. KASISKE BL, O'DONNELL MP, CLEARY MP, KEANE WF: Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney hit 33:667-672, 1988
2. KASISKE BL, O'DONNELL MP, GARVIS WJ, KEANE WF: Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure. Circ Res 62:367-374, 1988
3. HARRIS KPG, PURKERSON ML, YATES J, KLAHR S: Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome. Am J Kidney Dis 15:16-23, 1990
4. DIAMOND JR, HANCHAK NA, MCCARTER MD, KARNOVSKY MJ; Cholestyramine resin ameliorates chronic aminonucleoside nephrosis. Am J Clin Nutr 51:606-611, 1990
5. HIRANO T, MOROHOSHI T: Treatment of hyperlipidemia with probucol suppresses the development of focal and segmental glomerulo-sclerosis in chronic aminonucleoside nephrosis. Nephron 60:443-447, 1992
6. O'DONNELL MP, KASISKE BL, KIM Y, SCHMITZ PG, KEANE WF: Lovastatin retards the progression of established glomerular disease in obese Zucker rats. Am J Kidney Dis 22:83-59, 1993
7. RABELINK AJ, HEN RJ, ERKELENZ DW, JOLES JA, KOOMANS HA: Partial remission of nephrotic syndrome in patients on long-term simvastatin. Lancet 335:1045-1046, 1990
8. CHAN PCK, ROBINSON JD, YEUNG WC, CHENG KP, YEUNO HWD, TSANG MTS: Lovastatin in glomerulonephritis patients with hyperlipidemia and heavy proteinuria. Nephrol Dial Transplant 7:93-99, 1992
9. THOMAS ME, HARRIS KPG, RAMASWAMY C, HATTERSLEY JM, WHEELER DC, VARGHESE Z, WILLIAMS JD, WALLS J, MOORHEAD JF: Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. Kidney Int 44:1124-1129, 1993
10. SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY GROUP: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383-1389, 1994
11. GRETZ N, ECKER-TSCHIRNER KH, KÜHNLE HF, DAHL K, KIRSCHFINK M, DRESCHER P, LASSERER JJ, STRAUCH M: Practicability of the inuline plasma single-shot clearance. Contrib Nephrol 81:220-228, 1990
12. TER WEE PM, DE MICHELI AG, EPSTEIN M: Effects of calcium antagonists on renal hemodynamics and progression of nondiabetic chronic renal disease. Arch Intern Med 154:1185-1191, 1994